13D Filing: Alan Wayne Schoenbart and Echo Therapeutics Inc. (NASDAQ:ECTE)

Page 2 of 4 – SEC Filing

 
CUSIP
No. 27876L107                                                                                                                      
Page 2 of 4
Pages
 
 
1 NAMES
OF REPORTING PERSONS
     I.R.S.
IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
 
     Alan
W. Schoenbart

_________________________________________________________________________________
 
2 CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See
Instructions)
 
(a) [
]
 
(b) [
]

_________________________________________________________________________________
 
3 SEC
USE ONLY
 
 

_________________________________________________________________________________
 
4
SOURCE OF FUNDS (See Instructions)
          OO
 

_________________________________________________________________________________
 
5 CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS
     2(d)
OR 2(e) [ ]
 

_________________________________________________________________________________
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
      United
States of America
 


 
 
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
7        SOLE
VOTING POWER
774,500
(1)
8        SHARED
VOTING POWER
         0
9        SOLE
DISPOSITIVE POWER
774,500
(1)
10        SHARED
DISPOSITIVE POWER
0
 
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
PERSON
 
 
774,500
(1)

_________________________________________________________________________________
 
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
 
            
(See Instructions)
[ ]

_________________________________________________________________________________
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
 
5.6%

_________________________________________________________________________________
 
14 TYPE
OF REPORTING PERSON (See Instructions)
 
IN
 _________________________________________________________________________________
 
(1)
Includes 600,000
shares underlying currently exercisable stock options.
 
 

Follow Echo Therapeutics Inc. (NASDAQ:ECTE)